[ad_1]
Public-Private Partnership Supporting Diagnostic Testing in Vulnerable Communities has Provided $2.6 Million to US Clinics Since 2017 to Help Improve Patient Outcomes and Health Equity
FRANKLIN LAKES, NJ, Sept. 29, 2022 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, in conjunction with Heart to Heart International (HHI), the National Association of Free and Charitable Clinics (NAFC) and Henry Schein Cares, today announced that six US free and charitable clinics will be awarded product- based grants worth a total of $360,000 to support point-of-care diagnostic testing in communities with underserved and at-risk patient populations.
The BD Point-of-Care, Enhancing Clinical Effectiveness (PoCECE) initiative will provide the clinics with laboratory equipment to evaluate patients and receive diagnostic test results while still onsite. The initiative focuses on diagnosing the most common health issues faced by vulnerable patients in underserved populations, including high cholesterol, diabetes, urinary tract infections , kidney disease, blood clotting disorders, liver disease, strep A, HIV, hepatitis C, flu A & B, RSV and pregnancy tests.
Recipients of the 2022 PoCECE grants are:
- Agape Medical Clinic, Inc. – Weatherford, Oklahoma
- Esperanza Center – Associated Catholic Charities, Inc. – Baltimore, Maryland
- La Clinica Gratis of Community Initiatives, Inc – Greenwood, South Carolina
- Viola Startzman Clinic – Wooster, Ohio
- Premier Mobile Health Services – Fort Meyers, Florida
- The Free Clinics – Hendersonville, North Carolina
The grants include a Clinical Laboratory Improvement Amendment (CLIA)-waived point-of-care test system consisting of instruments and tests, as well as clinician training and technical support provided by BD employee volunteers to help ensure proper setup and use of equipment.
The PoCECE initiative launched in 2017 and has supported 27 US clinics in 20 states with product and cash donations totaling $2.6 million. With this year’s grant, more than 16,500 patient visits are expected to be positively impacted through enhanced diagnostic capabilities.
“This program and partnership with BD, NAFC and Henry Schein fit wholly within Heart to Heart International’s mission to improve health access for people in need across the United States,” says Kim CarrollHHI CEO. “By utilizing this laboratory technology, clinics can deliver timely lab results and are ultimately able to positively impact the diagnoses and health care for thousands of people in underserved communities throughout the country.”
Ellen Raffertysenior manager of Social Investing at BD said, “The recipients of this year’s grant are …
Full story available on Benzinga.com
[ad_2]
Source link
